Article Text
Statistics from Altmetric.com
QUESTION: In patients who had had dyspepsia for > 4 weeks, are testing and endoscopy as cost-effective as usual management for dyspepsia?
Design
Cost-effectiveness analysis from a health service perspective of a randomised (allocation concealed*), unblinded,* controlled trial with 18 months of follow up.
Setting
31 primary care centres in the UK.
Patients
478 patients (mean age 37 y, 57% men) who had had dyspepsia (epigastric pain or heartburn with or without nausea and bloating) for > 4 weeks. Exclusion criteria included patients who had had endoscopy or a positive result on barium meal examination in the previous 3 years or were unable to give informed consent. 99% of patients completed the trial.
Intervention
Patients were allocated to testing (Helisal test), and endoscopy (n=285) or usual management (n=193). Endoscopies on patients with positive …
Footnotes
-
Sources of funding: National Health Services; The Astra Foundation supplied the Helisal tests.
-
For correspondence: Dr B C Delaney, University of Birmingham Medical School, Department of General Practice, Vincent Drive, Edgbaston, Birmingham, BI5 2TT, UK. Fax +44 (0) 121 414 6571.